SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-004031
Filing Date
2019-05-30
Accepted
2019-05-30 08:05:19
Documents
4
Period of Report
2019-05-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_052919.htm 8-K 26111
2 POSTER PRESENTATION ex99-01.htm EX-99.01 18543
3 PRESS RELEASE DATED MAY 30, 2019 ex99-02.htm EX-99.02 16750
4 GRAPHIC ex99-01_002.jpg GRAPHIC 613532
  Complete submission text file 0001387131-19-004031.txt   907858
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 19864633
SIC: 2834 Pharmaceutical Preparations